To include your compound in the COVID-19 Resource Center, submit it here.

Pluristem Therapeutics, United Therapeutics deal

Pluristem's Pluristem Ltd. subsidiary granted United Therapeutics exclusive, worldwide rights to use its allogeneic, placental-derived expanded (PLX) cells

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE